Posted on 9/27/17
Bellerophon Announces $23 Million Private Placement
WARREN, N.J., Sept. 27, 2017 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, announced today that it has entered into a definitive securities . . .
Posted on 9/27/17
Pfizer's Loss Of Exclusivity Is Exaggerated
Concerns about LOE, or loss of exclusivity, and lack of revenue growth at Pfizer (PFE) are vastly overblown. The company is set to grow in the . . .
Posted on 9/27/17
Celgene's (CELG) Management Presents at Cantor Fitzgerald 3rd Annual Healthcare Conference (Transcript)
Celgene Corporation (NASDAQ:CELG)Cantor Fitzgerald 3rd Annual Healthcare ConferenceSeptember 26, 2017 09:45 A.M. ETExecutivesNadim Ahmed - President, Hematology and OncologyAnalystsMara Goldstein - Cantor FitzgeraldUnidentified Analyst -Mara GoldsteinHi, . . .
Posted on 9/27/17
Kadmon Prices Public Offerings of Common Stock and Warrants
NEW YORK--(BUSINESS WIRE)--Kadmon Holdings, Inc. (NYSE:KDMN) today announced the pricing of public offerings of an aggregate of 24,000,000 shares of its common stock together with accompanying . . .
Posted on 9/26/17
Melinta Therapeutics Provides for Distribution of Delafloxacin to 19 Countries
NEW HAVEN, Conn., Sept. 26, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held commercial-stage company developing novel antibiotics to treat serious bacterial infections, announced that . . .
Posted on 9/26/17
Johnson & Johnson Is Not A Good Buy
By applying different what-if scenarios to Johnson & Johnson (JNJ), I arrived at a conclusion that a fair value would be more likely in the 70$ . . .
Posted on 9/26/17
Pfizer's Ibrance To Rally Share Price Past $40
Shares of Pfizer Inc. (NYSE:PFE) are finally starting to catch a bid which is encouraging. Shares have been pretty much range bound for the past 24 . . .
Posted on 9/26/17
Johnson & Johnson Vs. Pfizer: Which Is A Better Buy?
Investment ThesisBoth Pfizer (PFE) and Johnson & Johnson (JNJ) are among the leading pharmaceutical companies in the world where J&J’s business also extends to consumer health . . .
Posted on 9/26/17
Bristol-Myers Squibb Achieves Earlier Than Expected Win
Recently, the FDA had approvedBristol-Myers Squibb (BMY) immuno-oncology drug Opdivo, for use in patients with hepatocellular carcinoma (liver cancer) who failed prior therapy. These were patients . . .
Posted on 9/26/17
Why General Electric Company Should Sell Its Healthcare Business
General Electric Company (NYSE:GE) CEO John Flannery has a job to do if he wants to restore investors' confidence in the blue chip industrial stock in . . .
Posted on 9/26/17
Brammer Bio Expands Cell and Gene Therapy Capacity in Florida and Massachusetts
Brammer Bio, a leading cell and gene therapy contract developing and manufacturing organization (CDMO), has confirmed expansions in its early clinical phase facility in Alachua, Florida . . .
Posted on 9/26/17
Sema4 Partners with PWNHealth
STAMFORD, Conn. & SAN DIEGO--(BUSINESS WIRE)--Sema4, a health information company providing advanced genomic testing, and PWNHealth, whose physicians and genetic counselors provide medical oversight and counseling . . .
Posted on 9/26/17
CURE Media Group Expands Strategic Alliance Partnership Program With The National Pancreas Foundation
CRANBURY, N.J.--(BUSINESS WIRE)--CURE Media Group proudly announces the addition of The National Pancreas Foundation (NPF) to its Strategic Alliance Partnership Program (SAP program). The collaboration will . . .
Posted on 9/25/17
J&J: Thoughts On Sirukumab And Other Problems
BackgroundIn my 8 articles on Johnson & Johnson (NYSE:JNJ) over the past 3 1/2 years, I have alternated between liking the stock and being neutral on . . .
Posted on 9/25/17
Better Buy: Celgene Corporation vs. Merck & Co., Inc.
Based on recent history, Celgene Corporation (NASDAQ:CELG) and Merck & Co.(NYSE:MRK) stocks don't even belong in the same league. Celgene stock is up more than 270% . . .
Posted on 9/25/17
Better Buy: Kimberly-Clark Corp. vs. Johnson & Johnson
There aren't many companies that can grow sales and profits through a wide range of market conditions. But both Kimberly-Clark (NYSE:KMB), the consumer goods specialist, and . . .
Posted on 9/22/17
Johnson & Johnson Acquires Sightbox
Quick TakeJohnson & Johnson Vision Care (JNJ) announced that it has acquired Sightboxfor an undisclosed amount.Sightbox has created a subscription membership service for contact lens wearers . . .
Posted on 9/22/17
Pfizer and Johnson & Johnson's Brewing Brawl Gets Real
Pfizer (NYSE:PFE) took direct aim at Johnson & Johnson (NYSE:JNJ) last year when it won FDA approval for Inflectra, a biosimilar to Johnson & Johnson's multi-billion . . .
Posted on 9/21/17
Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets
Provention Bio, Inc., a clinical stage biopharmaceutical company dedicated to sourcing, developing and commercializing novel therapeutics aimed at intercepting and preventing immune-mediated diseases, announced today that . . .
Posted on 9/21/17
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on September 18, 2017 it approved non-statutory stock options to purchase an aggregate of 32,500 shares of its . . .
Posted on 9/21/17
iMedicare and Mirixa Announce Partnership
NEW YORK--(BUSINESS WIRE)--iMedicare, the leading decision automation platform for pharmacies, and Mirixa Corporation, a leading healthcare technology and services company offering Medication Therapy Management (MTM), adherence, . . .
Posted on 9/21/17
Lisa Estrada Joins Movement to Raise $1 Million for Kidney Health
NEW YORK--(BUSINESS WIRE)--The National Kidney Foundation (NKF) announces that Lisa Estrada, senior vice president and chief compliance officer for Fresenius Medical Care North America (FMCNA), has . . .
Posted on 9/21/17
Evariant to Showcase Leading Patient Acquisition and Retention Solutions at SHSMD Connections 2017
FARMINGTON, Conn.--(BUSINESS WIRE)--Evariant, the leading healthcare CRM data analytics platform, announced today it is a Diamond Sponsor of SHSMD Connections 2017, the premier conference for healthcare . . .
Posted on 9/21/17
Landos Biopharma Raises $10M Series A Led by Perceptive Advisors
Landos Biopharma, Inc., an emerging biopharmaceutical company focused on developing improved treatments for
Posted on 9/21/17
Pfizer and Johnson & Johnson's Brewing Brawl Gets Real
Pfizer (NYSE:PFE) took direct aim at Johnson & Johnson (NYSE:JNJ) last year when it won FDA approval for Inflectra, a biosimilar to Johnson & Johnson's multi-billion . . .

